Trial Profile
Irbesartan versus placebo in combination with standard cardiovascular protection ACE-I [ACE inhibitor] therapy with ramipril for the treatment of albuminuria in hypertensive subjects at elevated cardiovascular risk.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2021
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary) ; Ramipril (Primary)
- Indications Hypertension; Proteinuria
- Focus Therapeutic Use
- Acronyms IMPROVE
- Sponsors Bristol-Myers Squibb
- 12 Jul 2007 New trial record.